| David H Bellamah, MD | |
|
2975 Stockyard Rd, Missoula, MT 59808-1557 | |
| (406) 541-3200 | |
| (406) 541-3201 |
| Full Name | David H Bellamah |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 28 Years |
| Location | 2975 Stockyard Rd, Missoula, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760426647 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 9851 (Montana) | Secondary |
| 208600000X | Surgery | 9851 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bellamah Vein And Surgery Pllc | 9032338033 | 2 |
News Archive
New research which suggests a direct link between smoking and brain damage will be published in the July issue of the Journal of Neurochemistry. Researchers, led by Debapriya Ghosh and Dr Anirban Basu from the Indian National Brain Research Center (NBRC), have found that a compound in tobacco provokes white blood cells in the central nervous system to attack healthy cells, leading to severe neurological damage.
In a bid to help clarify the all-but-transparent requirements needed In a bid to help clarify the all-but-transparent requirements needed to produce a compliant Clinical Evaluation Report (CER), Maetrics, a leading international consulting firm focused on the life sciences sector, has drafted a free go-to guide for Medical Device manufacturers downloadable here: Maetrics guide.
New data from an independent prospective study presented last week at the 19th European Congress of Psychiatry shows treatment with Risperdal Consta is associated with a lower risk of hospitalisation in patients with schizophrenia compared to treatment with other antipsychotics over a 12-month period.
XenoPort, Inc. announced today that it has been awarded a grant from The Michael J. Fox Foundation for Parkinson's Research to support a preclinical study of the efficacy and safety of a novel, orally administered prodrug of acamprosate in reducing L-Dopa induced dyskinesias (LID) in a pre-clinical model of Parkinson's disease.
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
› Verified 8 days ago
| Entity Name | Bellamah Vein & Surgery Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427469725 PECOS PAC ID: 9032338033 Enrollment ID: O20140923001846 |
News Archive
New research which suggests a direct link between smoking and brain damage will be published in the July issue of the Journal of Neurochemistry. Researchers, led by Debapriya Ghosh and Dr Anirban Basu from the Indian National Brain Research Center (NBRC), have found that a compound in tobacco provokes white blood cells in the central nervous system to attack healthy cells, leading to severe neurological damage.
In a bid to help clarify the all-but-transparent requirements needed In a bid to help clarify the all-but-transparent requirements needed to produce a compliant Clinical Evaluation Report (CER), Maetrics, a leading international consulting firm focused on the life sciences sector, has drafted a free go-to guide for Medical Device manufacturers downloadable here: Maetrics guide.
New data from an independent prospective study presented last week at the 19th European Congress of Psychiatry shows treatment with Risperdal Consta is associated with a lower risk of hospitalisation in patients with schizophrenia compared to treatment with other antipsychotics over a 12-month period.
XenoPort, Inc. announced today that it has been awarded a grant from The Michael J. Fox Foundation for Parkinson's Research to support a preclinical study of the efficacy and safety of a novel, orally administered prodrug of acamprosate in reducing L-Dopa induced dyskinesias (LID) in a pre-clinical model of Parkinson's disease.
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David H Bellamah, MD 2975 Stockyard Rd, Missoula, MT 59808-1557 Ph: (406) 541-3200 | David H Bellamah, MD 2975 Stockyard Rd, Missoula, MT 59808-1557 Ph: (406) 541-3200 |
News Archive
New research which suggests a direct link between smoking and brain damage will be published in the July issue of the Journal of Neurochemistry. Researchers, led by Debapriya Ghosh and Dr Anirban Basu from the Indian National Brain Research Center (NBRC), have found that a compound in tobacco provokes white blood cells in the central nervous system to attack healthy cells, leading to severe neurological damage.
In a bid to help clarify the all-but-transparent requirements needed In a bid to help clarify the all-but-transparent requirements needed to produce a compliant Clinical Evaluation Report (CER), Maetrics, a leading international consulting firm focused on the life sciences sector, has drafted a free go-to guide for Medical Device manufacturers downloadable here: Maetrics guide.
New data from an independent prospective study presented last week at the 19th European Congress of Psychiatry shows treatment with Risperdal Consta is associated with a lower risk of hospitalisation in patients with schizophrenia compared to treatment with other antipsychotics over a 12-month period.
XenoPort, Inc. announced today that it has been awarded a grant from The Michael J. Fox Foundation for Parkinson's Research to support a preclinical study of the efficacy and safety of a novel, orally administered prodrug of acamprosate in reducing L-Dopa induced dyskinesias (LID) in a pre-clinical model of Parkinson's disease.
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
› Verified 8 days ago
Charles J Swannack, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway, Missoula, MT 59802 Phone: 406-542-7525 Fax: 406-829-0661 | |
Dr. Vern Hicks Horton, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2827 Fort Missoula Rd, Community Medical Center, Missoula, MT 59804 Phone: 406-728-4100 Fax: 406-327-4502 | |
Jason Richard Hurd, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-329-5615 Fax: 406-329-2791 | |
Lori A Grimsley, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-542-7525 Fax: 406-542-7592 | |
Anne Manktelow, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2835 Fort Missoula Road, Ste 306 Pediatric Surgery Of Montana, Missoula, MT 59804 Phone: 406-327-4730 | |
Deron Ludwig, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St Fl 5, Missoula, MT 59802 Phone: 406-329-5866 Fax: 406-329-5864 | |
Louis X Kattine, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2819 Great Northern Loop Ste 200, Missoula, MT 59808 Phone: 406-542-7525 Fax: 406-829-0661 |